Home > Healthcare > Medical Devices > Diagnostic Devices > Intracranial Pressure (ICP) Monitoring Devices Market

Intracranial Pressure (ICP) Monitoring Devices Market Share

Report ID: GMI3339
Published Date: Feb 2024
Report Format: PDF

Download Free Sample

Intracranial Pressure Monitoring Devices Market Share

The intracranial pressure (ICP) monitoring devices industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced devices based on different technologies is among a key market strategy. Some of the leading industry players including, Luciole Medical AG, Medtronic plc, Johnson & Johnson among others have a notable presence in the market.

Intracranial Pressure Monitoring Devices Market Companies

Some of the eminent market participants operating in the intracranial pressure (ICP) monitoring devices industry include:

Brain4Care Inc.
CranioSense, LLC.
HeadSense Medical Ltd
Integra LifeScience Holdings Corporation
Johnson & Johnson
Luciole Medical AG
Medtronic plc
Natus Medical Incorporated
RAUMEDIC AG
Sophysa
Vittamed Corporation

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of intracranial pressure (ICP) monitoring devices reached USD 1.7 billion in 2023 and is set to witness 6.8% CAGR from 2024 to 2032, owing to the increasing prevalence of various neurological disorders and traumatic accidents.

The invasive segment is estimated to account for USD 2.5 billion by 2032, as it allows for direct measurement of intracranial pressure, providing highly accurate and reliable data for clinical decision-making.

North America market held over USD 701.7 million in 2023, due to the growing prevalence of neurological conditions and traumatic brain injuries, coupled with advancements in medical technology.

Brain4Care Inc., CranioSense, LLC, HeadSense Medical Ltd., Integra LifeScience Holdings Corporation, Johnson & Johnson, Luciole Medical AG, Medtronic plc, Natus Medical Inc., RAUMEDIC AG, Sophysa, and Vittamed Corporation.